Amiodarone Accord 30 mg/ml injektio/infuusiokonsentraatti, liuosta varten Finland - Finnish - Fimea (Suomen lääkevirasto)

amiodarone accord 30 mg/ml injektio/infuusiokonsentraatti, liuosta varten

accord healthcare b.v. - amiodarone hydrochloride - injektio/infuusiokonsentraatti, liuosta varten - 30 mg/ml - amiodaroni

Thiopental Panpharma 1 g injektiokuiva-aine, liuosta varten Finland - Finnish - Fimea (Suomen lääkevirasto)

thiopental panpharma 1 g injektiokuiva-aine, liuosta varten

panpharma - thiopental sodium - injektiokuiva-aine, liuosta varten - 1 g - tiopentaali

Thiopental Panpharma 0.5 g injektiokuiva-aine, liuosta varten Finland - Finnish - Fimea (Suomen lääkevirasto)

thiopental panpharma 0.5 g injektiokuiva-aine, liuosta varten

panpharma - thiopental sodium - injektiokuiva-aine, liuosta varten - 0.5 g - tiopentaali

Celdoxome pegylated liposomal European Union - Finnish - EMA (European Medicines Agency)

celdoxome pegylated liposomal

yes pharmaceutical development services gmbh - doksorubisiinihydrokloridia - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastiset aineet - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).

Loceryl 5 % lääkekynsilakka Finland - Finnish - Fimea (Suomen lääkevirasto)

loceryl 5 % lääkekynsilakka

galderma nordic ab - amorolfine hydrochloride - lääkekynsilakka - 5 % - amorolfiini

Amorolfin ratiopharm 5 % lääkekynsilakka Finland - Finnish - Fimea (Suomen lääkevirasto)

amorolfin ratiopharm 5 % lääkekynsilakka

ratiopharm gmbh - amorolfine hydrochloride - lääkekynsilakka - 5 % - amorolfiini

NAROPIN 2 mg/ml injektio-/infuusioneste, liuos Finland - Finnish - Fimea (Suomen lääkevirasto)

naropin 2 mg/ml injektio-/infuusioneste, liuos

aspen pharma trading limited - ropivacaini hydrochloridum - injektio-/infuusioneste, liuos - 2 mg/ml - ropivakaiini

NAROPIN 7.5 mg/ml injektioneste, liuos Finland - Finnish - Fimea (Suomen lääkevirasto)

naropin 7.5 mg/ml injektioneste, liuos

aspen pharma trading limited - ropivacaini hydrochloridum - injektioneste, liuos - 7.5 mg/ml - ropivakaiini

NAROPIN 10 mg/ml injektioneste, liuos Finland - Finnish - Fimea (Suomen lääkevirasto)

naropin 10 mg/ml injektioneste, liuos

aspen pharma trading limited - ropivacaini hydrochloridum - injektioneste, liuos - 10 mg/ml - ropivakaiini

NAROPIN 5 mg/ml injektioneste, liuos Finland - Finnish - Fimea (Suomen lääkevirasto)

naropin 5 mg/ml injektioneste, liuos

aspen pharma trading limited - ropivacaini hydrochloridum - injektioneste, liuos - 5 mg/ml - ropivakaiini